Table 2.
Results of assay of two dosage forms Prandglim plus® and Piompride® (4/30) using proposed models
| Prandglim plus® (25/30) | Piompride® (4/30) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % Recovery | % Recovery | ||||||||||||||||||||||
| Added conc. | PLS | ANN | SVR | XG-boost | Added conc. | PLS | ANN | SVR | XG-boost | ||||||||||||||
| PIO | ALG | PIO | PIO | ALG | PIO | ALG | PIO | ALG | PIO | GLM | PIO | PIO | PIO | PIO | GLM | ||||||||
| 27.00 | 22.50 | 100.72 | 102.20 | 95.15 | 100.15 | 104.84 | 99.96 | 103.91 | 30.00 | 4.00 | 102.25 | 100.29 | 101.30 | 101.92 | 100.33 | ||||||||
| 33.00 | 27.50 | 104.48 | 105.70 | 99.04 | 100.35 | 105.17 | 102.09 | 104.99 | 33.00 | 4.40 | 100.87 | 99.72 | 99.57 | 100.30 | 98.68 | ||||||||
| 36.00 | 30.00 | 106.15 | 100.46 | 97.46 | 98.09 | 104.55 | 100.00 | 99.35 | 36.00 | 4.60 | 95.29 | 93.29 | 92.89 | 93.24 | 97.36 | ||||||||
| Mean % | 103.78 | 102.79 | 97.22 | 99.53 | 104.86 | 100.68 | 103.28 | 99.47 | 97.76 | 97.92 | 98.37 | 98.79 | |||||||||||
| SD | 2.78 | 2.67 | 1.96 | 1.25 | 0.31 | 1.22 | 3.00 | 3.68 | 3.88 | 4.44 | 4.62 | 1.49 | |||||||||||
SD; standard deviation